newsfilter
← Latest News
GlobeNewswire·

Selecta Biosciences to Participate at the Guggenheim Healthcare Talks | 4th Annual Immunology & Neurology Day

WATERTOWN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company pioneering precision immune tolerance with its clinically validated ImmTOR® platform to develop